Skip to main content

Biolase, Inc

BIOLDelisted Sep 6, 2024
Industry
Dental Equipment & Supplies
SEC CIK
0000811240

Biolase, Inc was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 12, 2023; 29 institutions reported holding it in 13F filings for Q2 2023, worth $311.8K in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Biolase, Inc changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of BIOL: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders4750+3
Shares22.5M17.6M−4.98M (−22.1%)
Value$14.4M$6.85M−$7.56M (−52.4%)

New holders (14)

Institutions that held Biolase, Inc at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to BIOL in Q4 2021
InstitutionSharesValue% of portfolio
Acadian Asset Management LLC80,790$31.0K0.00%
Avantax Planning Partners, Inc.60,000$23.0K0.00%
HRT Financial LP52,376$20.0K0.00%
Virtue Capital Management, LLC35,000$14.0K0.00%
Bayesian Capital Management, LP21,500$8.00K0.00%
Apollon Wealth Management, LLC20,000$8.00K0.00%
Arete Wealth Advisors, LLC13,000$5.00K0.00%
JPMorgan Chase & Co4,546$2.00K0.00%
Barclays PLC4,000$2.00K0.00%
Koshinski Asset Management, Inc.3,000$1.17K0.00%
CoreCap Advisors, LLC1,104$1.00K0.00%
Surevest, LLC1,000$00.00%
Aquire Wealth Advisors, LLC23$00.00%
Bivin & Associates, Inc.1,000$00.00%

Sold out (11)

Institutions that held Biolase, Inc at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of BIOL in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Gsa Capital Partners LLP1,254,547$802.0K
Two Sigma Advisers, LP387,500$248.0K
Two Sigma Investments, LP192,559$123.0K
Citadel Advisors LLC87,626$56.0K
Credit Suisse AG46,016$29.0K
Jane Street Group, LLC40,874$26.0K
CFO4Life Group, LLC33,200$21.0K
Goldman Sachs Group Inc24,008$15.0K
Tower Research Capital LLC (TRC)2,371$2.00K
1832 Asset Management L.P.1,000$1.00K
Harbour Investments, Inc.352$0